Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Savara, Inc. - Common Stock (NQ:SVRA)

2.840 -0.090 (-3.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Savara, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Savara Inc. (NASDAQ: SVRA) Making Surprising Moves in Monday Session
Via Investor Brand Network
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
Savara to Present at Two Upcoming Healthcare Conferences
From Savara Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Savara Inc. (NASDAQ: SVRA) is a Stock Spotlight on 11/16
Via Investor Brand Network
Savara Inc. (NASDAQ: SVRA) is a Stock Spotlight on 11/6
Via Investor Brand Network
Savara Inc. (NASDAQ: SVRA) is a Stock Spotlight on 10/25
Via Investor Brand Network
Savara Inc. (NASDAQ: SVRA) is a Stock Spotlight on 10/20
Via Investor Brand Network
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
From Savara Inc.
Via Business Wire
Savara Added to the NASDAQ Biotechnology Index
From Savara Inc.
Via Business Wire
Savara Inc. (NASDAQ: SVRA) is a Stock Spotlight on 10/10
Via Investor Brand Network
Savara Inc. (NASDAQ: SVRA) is a Stock Spotlight on 9/27
Via Investor Brand Network
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
Savara to Present at the Piper Sandler 35th Annual Healthcare Conference
From Savara Inc.
Via Business Wire
Savara Reports Third Quarter Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara to Present at the Jefferies London Healthcare Conference
From Savara Inc.
Via Business Wire
5 OTC Stocks With The Potential To Explode In 2024
Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms. 
Via Benzinga
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
3 Penny Stocks to Provide 1,000% Returns Over the Next Decade
Consider three intriguing penny stocks for investors looking to add a bit more risk to their portfolio in times like these. 
Via InvestorPlace
The 3 Best Penny Stocks to Buy Now: September 2023
When all the focus lies on the largest names of the economy, these best penny stocks to buy offer a great risk/reward ratio. 
Via InvestorPlace
Topics Economy
Exposures Economy
Savara to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Savara Inc.
Via Business Wire
Savara Reports Second Quarter Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mixed, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) shares rose... 
Via Benzinga
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
From Savara Inc.
Via Business Wire
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Savara Added to Russell 3000® Index
From Savara Inc.
Via Business Wire
Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
From Savara Inc.
Via Business Wire
Savara to Present at the Jefferies Healthcare Conference
From Savara Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS